About Decheng Capital Global Life
Decheng Capital Global Life is a venture capital firm based in Menlo Park, CA. Since October 2020 it has filed Form D notices for three funds and one related vehicle. The largest, Decheng Capital Global Life Sciences Fund V, L.P., reported $452.0M raised from 42 investors.
Funds
Decheng Capital Global Life has three funds on file with the SEC, plus one feeder, opportunity or co-investment vehicle. The funds have reported $601.0M raised.
Funds (SEC Form D)
| Fund | First filed | Amount raised | Target | Investors |
|---|---|---|---|---|
| Decheng Capital Global Life Sciences Fund V, L.P.Venture capital fund · 3(c)(1), 3(c)(7) · Form D/A ↗ | Jun 17, 2024 | $452,000,000Jun 2024: $0 Oct 2025: $452.0M | $700,000,000 | 42 |
| Decheng Capital Global Life Sciences Fund IV, L.P.Venture capital fund · 3(c)(1), 3(c)(7) · Form D ↗ | Dec 15, 2020 | None yet | $650,000,000 | — |
| Decheng Capital Global Healthcare Fund, LPHedge fund · 3(c)(7) · Form D/A ↗ | Oct 9, 2020 | $149,000,000Oct 2020: $0 Oct 2021: $98.0M Oct 2022: $139.0M Oct 2026: $149.0M | Not set | 7 |
Amounts and investor counts come from each fund's latest Form D or amendment; the dated lines under an amount show what earlier filings reported. "Not set" means the fund did not give a target. Form D does not report returns.
Feeder, opportunity and co-investment vehicles (1)
| Vehicle | Kind | First filed | Amount raised | Investors | Filing |
|---|---|---|---|---|---|
| Decheng Capital Global Healthcare Fund (Offshore), LP | Feeder or parallel fund | Oct 9, 2020 | $33,100,000 | 9 | Form D ↗ |
These vehicles usually hold a single investment or a small group of them. Their filings do not name the companies they hold.
Portfolio Companies
Companies where a Decheng Capital Global Life partner sits on the board, according to the company's own Form D. A board seat usually comes with an investment, but Form D does not list investors.
| Company | Location | Decheng Capital Global Life director | On the board | Latest raise |
|---|---|---|---|---|
| Baylor Genetics Holdings, Inc. | Houston, TX | Xiangmin Cui | 2026 | $49.9M ↗Jul 2026 |
| ImmPACT Bio USA Inc. | West Hills, CA | Xiangmin Cui | 2022–2024 | $139.8M ↗Jan 2022 |
| SunnyBay BioTech, Inc. | Fremont, CA | Xiangmin Cui | 2023 | $2.2M ↗Jan 2023 |
| LevitasBio, Inc. | Menlo Park, CA | Xiangmin Cui | 2017–2021 | $11.7M ↗Mar 2024 |
People
Partners and officers named on Decheng Capital Global Life's fund filings.
Sources
- SECEvery Form D filing behind this page is linked in the tables above.